Oncology Institute (DFPH) Free Cash Flow (2020 - 2026)

Oncology Institute has reported Free Cash Flow for 7 years, with the latest figure at -$3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 38.73% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$25.7 million (down 33.06% YoY), and the FY2025 full-year result was -$27.8 million, up 8.38% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$3.3 million, down from $2.2 million in the prior quarter.
• The five-year high for Free Cash Flow was $2.2 million in Q4 2024, with the low at -$21.6 million in Q3 2022.
• Historically, Free Cash Flow has averaged -$9.7 million across 5 years, with a median of -$10.5 million in 2022.
• Annual changes were most pronounced in 2022 — Free Cash Flow sank 11501.94% — and 2024, when it soared 147.22%.
• Oncology Institute's Free Cash Flow stood at -$10.5 million in 2022, then jumped by 54.56% to -$4.8 million in 2023, then soared by 147.22% to $2.2 million in 2024, then dropped by 3.21% to $2.2 million in 2025, then tumbled by 249.88% to -$3.3 million in 2026.
• The last three Free Cash Flow figures came in at -$3.3 million (Q1 2026), $2.2 million (Q4 2025), and -$13.2 million (Q3 2025), per Business Quant data.